TIVITY HEALTH, INC.

(TVTY)
Delayed Nasdaq  -  04:00 2022-06-27 pm EDT
32.50 USD   +0.06%
07/08TIVITY HEALTH, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
07/08Tivity Health, Inc. Terminates Adam Holland as Chief Financial Officer
CI
06/29TIVITY HEALTH, INC.(NASDAQGS : TVTY) dropped from S&P Health Care Services Select Industry Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

TIVITY HEALTH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)

02/25/2022 | 02:46pm EDT

Please read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes included under Item 8. "Financial Statements and Supplementary Data" of this report.

Overview

Tivity Health, Inc. (the "Company"), was founded and incorporated in Delaware in 1981. We are a leading provider of healthy life-changing solutions, including SilverSneakers®, Prime® Fitness, and WholeHealth Living®. We help adults improve their health and support them on life's journey by providing access to in-person and virtual physical activity, social engagement, and mental enrichment programs. We deliver resources that enable members to live healthier, happier, more connected lives. Our solutions support health plans and employers nationwide as they seek to reduce costs and improve health outcomes.

We offer SilverSneakers to approximately 18 million eligible members of Medicare Advantage, Medicare Supplement, and group retiree plans. We also offer Prime Fitness, a fitness facility access program, through commercial health plans, employers, and other sponsoring organizations. Our national network of fitness centers delivers both SilverSneakers and Prime Fitness. At December 31, 2021, our SilverSneakers fitness network encompassed approximately 16,000 locations. In January 2022, we launched a customizable, premium fitness network for SilverSneakers that increased our total SilverSneakers fitness network to approximately 23,000 locations. We also offer virtual fitness experiences, including live instructor-led classes. Through our WholeHealth Living program, which we sell primarily to health plans, we offer a continuum of services related to physical and integrative medicine. Our WholeHealth Living network includes relationships with approximately 29,000 physical and integrative medicine practitioner locations to serve individuals through health plans and employers who seek health services such as chiropractic care, acupuncture, physical therapy, occupational therapy, massage therapy, and more.

The Company is headquartered at 701 Cool Springs Boulevard, Franklin, Tennessee 37067.

COVID-19

COVID-19, the global pandemic first recognized by HHS as a national public health emergency in January 2020, continues to spread throughout the United States and other countries. Substantially all of the fitness centers in our national network were temporarily closed for portions of 2020, and the average monthly total participation levels of our members after such locations reopened were significantly below historical levels, thus adversely impacting our revenues during 2020 because a significant portion of revenues from our SilverSneakers program is based on member visits to a fitness partner location. Participation levels increased during 2021 but remained below pre-pandemic levels. SilverSneakers in-person visits totaled 58.4 million for 2021, compared to 46.0 million and 104.0 million for 2020 and 2019, respectively. In addition, while the number of active subscribers for Prime Fitness declined from April through December 2020, as of December 31, 2021, the number of active subscribers had increased slightly since the beginning of 2021.

Disposition of our Nutrition Business

Effective as of December 9, 2020, we completed the sale of Nutrisystem. Results of operations for Nutrisystem have been classified as discontinued operations for all periods presented in the consolidated financial statements.


                                       25

--------------------------------------------------------------------------------

Forward-Looking Statements

This report contains forward-looking statements, which are based upon current expectations, involve a number of risks and uncertainties, and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief, or expectations of the Company, including, without limitation, all statements regarding the Company's future earnings, revenues, financial condition, business strategies, and results of operations. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary from those in the forward-looking statements as a result of various factors, including, but not limited to:

   •  impacts from the COVID-19 pandemic (including the response of governmental
      authorities to combat and contain the pandemic; the development,
      availability, distribution, and effectiveness of vaccines and treatments,
      and public confidence in such vaccines and treatments; the closure of
      fitness centers in our national network (or operational restrictions imposed
      on such fitness centers), reclosures, and potential additional reclosures or
      restrictions as a result of surges in positive COVID-19 cases) on our
      business, operations or liquidity;



   •  the risks associated with changes in macroeconomic conditions (including the
      impacts of any recession or changes in consumer spending resulting from the
      COVID-19 pandemic), widespread epidemics, pandemics (such as the current
      COVID-19 pandemic, including variant strains of COVID-19) or other outbreaks
      of disease, geopolitical turmoil, and the continuing threat of domestic or
      international terrorism;



   •  our ability to collect accounts receivable from our customers and amounts
      due under our sublease agreements;



  • the market's acceptance of our new products and services;



   •  our ability to develop and implement effective strategies and to anticipate
      and respond to strategic changes, opportunities, and emerging trends in our
      industry and/or business, as well as to accurately forecast the related
      impact on our revenues and earnings;



   •  the impact of any impairment of our goodwill, intangible assets, or other
      long-term assets;



   •  changes in fair value of the Sharecare Equity Security and the expected
      timing and amount of cash proceeds from any potential disposition of this
      security;



   •  the expected timing, amount, and impact of any share repurchases made by the
      Company;



   •  our ability to attract, hire, or retain key personnel or other qualified
      employees and to control labor costs;



   •  our ability to effectively compete against other entities, whose financial,
      research, staff, and marketing resources may exceed our resources;



   •  the impact of legal proceedings involving us and/or our subsidiaries,
      products, or services, including any claims related to intellectual property
      rights, as well as our ability to maintain insurance coverage with respect
      to such legal proceedings and claims on terms that would be favorable to us;



   •  the impact of severe or adverse weather conditions, the current COVID-19
      pandemic (including variant strains of COVID-19), and the potential
      emergence of additional health pandemics or infectious disease outbreaks on
      member participation in our programs;



   •  the risks associated with deriving a significant concentration of our
      revenues from a limited number of our customers, many of whom are health
      plans;



   •  our ability and/or the ability of our customers to enroll participants and
      to accurately forecast their level of enrollment and participation in our
      programs in a manner and within the timeframe we anticipate;


                                       26

--------------------------------------------------------------------------------

   •  our ability to sign, renew and/or maintain contracts with our customers
      and/or our fitness partner locations under existing terms or to restructure
      these contracts on terms that would not have a material negative impact on
      our results of operations;



   •  the ability of our health plan customers to maintain the number of covered
      lives enrolled in those health plans during the terms of our agreements;



   •  our ability to add and/or retain active subscribers in our Prime Fitness
      program;



   •  the impact of any changes in tax rates, enactment of new tax laws, revisions
      of tax regulations, or any claims or litigation with taxing authorities;



   •  the impact of a reduction in Medicare Advantage health plan reimbursement
      rates or changes in plan design;



   •  the impact of any new or proposed legislation, regulations and
      interpretations relating to Medicare, Medicare Advantage, Medicare
      Supplement and privacy and security laws;



  • the impact of healthcare reform on our business;



   •  the risks associated with increased focus from investors and other
      stakeholders regarding ESG practices, which could result in additional
      costs, regulation, or risks and adversely impact our reputation, employee
      recruiting and retention, and willingness of customers and suppliers to do
      business with us;



   •  the risks associated with potential failures of our information systems or
      those of our third-party vendors, including as a result of telecommuting
      issues associated with personnel working remotely, which may include a
      failure to execute on policies and processes in a work-from-home or remote
      model;



   •  the risks associated with data privacy or security breaches, computer
      hacking, network penetration and other illegal intrusions of our information
      systems or those of third-party vendors or other service providers,
      including those risks that result from the increase in personnel working
      remotely, which may result in unauthorized access by third parties, loss,
      misappropriation, disclosure or corruption of customer, employee or our
      information, or other data subject to privacy laws and may lead to a
      disruption in our business, costs to modify, enhance, or remediate our
      cybersecurity measures, enforcement actions, fines or litigation against us,
      or damage to our business reputation;



   •  the risks associated with changes to traditional office-centered business
      processes and/or conducting operations out of the office in a work-from-home
      or remote model by us or our third-party vendors during adverse situations
      (e.g., during a crisis, disaster, or pandemic), which may result in
      additional costs and/or may negatively impact productivity and cause other
      disruptions to our business;



  • our ability to enforce our intellectual property rights;



   •  the risk that our indebtedness may limit our ability to adapt to changes in
      the economy or market conditions, expose us to interest rate risk for the
      variable rate indebtedness and require a substantial portion of cash flows
      from operations to be dedicated to the payment of indebtedness;



   •  our ability to service our debt, make principal and interest payments as
      those payments become due, and remain in compliance with our debt covenants;



   •  our ability to obtain adequate financing to provide the capital that may be
      necessary to support our current or future operations;




                                       27

--------------------------------------------------------------------------------

   •  counterparty risk associated with our interest rate swap agreements and
      changes in fair value of certain interest rate swap agreements that no
      longer qualify for hedge accounting treatment ("de-designated swaps"); and


   •  other risks detailed in this report and our other filings with the
      Securities and Exchange Commission.

We undertake no obligation to update or revise any such forward-looking statements.

Critical Accounting Policies

We describe our significant accounting policies in Note 1 of the notes to the consolidated financial statements. We prepare the consolidated financial statements in conformity with generally accepted accounting principles in the United States ("U.S. GAAP"), which requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and related disclosures at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.

We believe the following accounting policies are the most critical in understanding the estimates and judgments that are involved in preparing our financial statements and the uncertainties that could impact our results of operations, financial condition, and cash flows.

Revenue Recognition

We account for revenue from contracts with customers in accordance with Accounting Standards Codification ("ASC") Topic 606 "Revenue from Contracts with Customers" ("ASC Topic 606"). The unit of account in ASC Topic 606 is a performance obligation, which is a promise in a contract to transfer to a customer either a distinct good or service (or bundle of goods or services) or a series of distinct goods or services provided over a period of time. ASC Topic 606 requires that a contract's transaction price, which is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, is to be allocated to each performance obligation in the contract based on relative standalone selling prices and recognized as revenue when or as the performance obligation is satisfied.

We earn revenue from continuing operations primarily from three programs: SilverSneakers senior fitness, Prime Fitness and WholeHealth Living. We provide the SilverSneakers senior fitness program to members of Medicare Advantage, Medicare Supplement, and group retiree plans through our contracts with those plans. We offer Prime Fitness, a fitness facility access program, through contracts with commercial health plans, employers, and other sponsoring organizations that allow their members to individually purchase the program. We sell our WholeHealth Living program primarily to health plans.

The significant majority of our customer contracts contain one performance obligation - to stand ready to provide access to our network of fitness locations and fitness programming - which is satisfied over time as services are rendered each month over the contract term. Unsatisfied performance obligations at the end of a particular month primarily relate to certain monthly memberships for our Prime Fitness program, which are recorded as deferred revenue on the consolidated balance sheet and recognized as revenue during the immediately subsequent month. There was $0.1 million of revenue recognized during the year ended December 31, 2021 from performance obligations satisfied in a prior period.

Our fees are variable month to month and are generally billed per member per month ("PMPM") or billed based on a combination of PMPM and member visits to a network location. We bill PMPM fees by multiplying the contractually negotiated PMPM rate by the number of members eligible for or receiving our services during the month. We bill for member visits approximately one month in arrears once actual member visits are known. Payments from customers are typically due within 30 days of invoice date. When material, we capitalize costs to obtain contracts with customers and amortize them over the expected recovery period.

Our customer contracts include variable consideration, which is allocated to each distinct month over the contract term based on eligible members and/or member visits each month. The allocated consideration corresponds directly with the value to our customers of our services completed for the month. Under the majority of our contracts, we recognize revenue each month using the practical expedient available under ASC 606-10-55-18, which provides that revenue is recognized in the amount for which we have the right to invoice. ASC 606-10-50-


                                       28

--------------------------------------------------------------------------------

14(b) provides an optional exemption, which we have elected to apply, from disclosing remaining performance obligations when revenue is recognized from the satisfaction of the performance obligation in accordance with the "right to invoice" practical expedient.

Although we evaluate our financial performance and make resource allocation decisions based upon the results of our single operating and reportable segment, we believe the following information depicts how our revenues and cash flows from continuing operations are affected by economic factors. For the year ended December 31, 2021, revenue from our SilverSneakers program, which is predominantly contracted with Medicare Advantage and Medicare Supplement plans, comprised 75% of revenues from continuing operations, while revenue from our Prime Fitness and WholeHealth Living programs comprised 20% and 5%, respectively, of revenues from continuing operations.

Sales and usage-based taxes are excluded from revenues.

Impairment of Intangible Assets and Goodwill

We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable. Following the sale of Nutrisystem in December 2020, we have a single reporting unit.

As part of the annual impairment test, we may elect to perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If we elect not to perform a qualitative assessment or we determine that it is more likely than not that the fair value of the reporting unit is less than its carrying value, we perform a quantitative review. During the quantitative review, if the estimated fair value of the reporting unit exceeds its carrying amount, no impairment is indicated. If the estimated fair value of the reporting unit is less than its carrying amount, impairment of goodwill is measured as the excess of the carrying amount over fair value.

We review indefinite-lived intangible assets for impairment on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable. We estimate the fair value of our indefinite-lived tradename using the relief-from-royalty method, which requires us to estimate significant assumptions such as the long-term growth rates of future revenues associated with the tradename, the royalty rate for such revenue, the terminal growth rate of revenue, the tax rate, and a discount rate. Changes in these estimates and assumptions could materially affect the estimates of fair value for the tradename.

Key Performance Indicators

In managing our business, we regularly review and analyze a number of key performance indicators ("KPIs"), including revenues, adjusted EBITDA (both in dollars and as a percentage of revenues), and free cash flow. Adjusted EBITDA and free cash flow are not calculated in accordance with U.S. GAAP ("non-GAAP"). These KPIs help us monitor our performance, identify trends affecting our business, determine the allocation of resources, and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business.

During 2021, we updated our definition of adjusted EBITDA as follows: (i) during the first quarter of 2021 to exclude other (income) expense related to de-designated swaps; (ii) during the second quarter of 2021 to exclude loss on extinguishment and modification of debt; and (iii) during the third quarter of 2021 to exclude other (income) expense related to realized and unrealized gains and losses on our Sharecare Equity Security, as further described in Note 12 of the notes to consolidated financial statements included in this report. We consider such items to be outside the performance of our ongoing core business operations and believe that presenting Adjusted EBITDA excluding these items provides increased transparency as to the operating costs of our current business performance. We revised Adjusted EBITDA for 2020 to exclude other (income) expense incurred during the fourth quarter of 2020 related to de-designated swaps; except for this revision, we did not revise prior periods' Adjusted EBITDA amounts because there were no other costs in the prior periods similar in nature to the items that were newly excluded from Adjusted EBITDA during 2021.


                                       29

--------------------------------------------------------------------------------

Additionally, beginning in the fourth quarter of 2020, we revised the definition of free cash flow to exclude settlement on derivatives not designated as hedges, a new item for 2020 that did not exist in prior periods. Settlement on derivatives not designated as hedges arose in 2020 due to the de-designation of certain interest rate swaps in the fourth quarter of 2020 in connection with the repayment of a portion of the principal on the term loans under our Prior Credit Agreement, as further described in Note 14 of the notes to consolidated financial statements included in this report. We believe it is appropriate to exclude settlement on derivatives not designated as hedges from free cash flow because these payments are similar to interest payments (which are reflected in cash flow from operating activities) and they reduce our cash available to repay debt or make other investments. Beginning in the third quarter of 2021, we further revised the definition of free cash flow such that it includes proceeds from the sale of equity securities, a new item for 2021 related to our Sharecare Equity Security that did not exist in prior periods. We believe it is appropriate to include such proceeds in free cash flow because they are available to be used to support our business.

                                                    Year Ended December 31,
(In $000s)                                     2021          2020          2019

Revenues from continuing operations $ 481,252 $ 437,714 $ 633,066 Adjusted EBITDA from continuing operations 158,077 148,081 142,561 Adjusted EBITDA as a percentage of

  revenues from continuing operations             32.8 %        33.8 %        22.5 %



   •  Revenues - we review year-over-year changes in revenue from continuing
      operations as a key measure of our success in growing our business. In
      addition to measuring revenue in total, we also measure and report revenue
      by program type or source of revenue, as detailed in Note 4 of the notes to
      the consolidated financial statements included in this report, i.e.,
      SilverSneakers, Prime Fitness, WholeHealth Living, and Other. Evaluating
      revenue by program type or source helps us identify and address changes in
      product mix, broad market factors that may affect our revenues, and
      opportunities for future growth.



   •  Adjusted EBITDA is a non-GAAP measure and is defined by the Company as
      earnings before interest, taxes, depreciation and amortization, acquisition,
      integration, project and CEO transition costs, restructuring charges, loss
      on extinguishment and modification of debt, and other (income) expense. We
      believe adjusted EBITDA provides investors a helpful measure for comparing
      our operating performance with our historical operating results as well as
      the performance of other companies that may have different financing and
      capital structures or tax rates. We believe it is a useful indicator of the
      operational strength and performance of our business. Because adjusted
      EBITDA may be defined differently by other companies in our industry, the
      financial measure presented herein may not be comparable to similarly titled
      measures of other companies.  A reconciliation of adjusted EBITDA to income
      from continuing operations (the most comparable U.S. GAAP measure) is set
      forth below.



                                                       Year Ended December 31,
(In thousands)                                  2021            2020            2019
Income from continuing operations, GAAP
basis                                        $   107,376     $    56,869     $    45,217
Income tax expense                                26,345          17,530          20,293
Interest expense                                  34,762          43,477          41,803
Depreciation expense                              11,298           9,930           7,137
EBITDA from continuing operations,
non-GAAP basis (1)                           $   179,781     $   127,806     $   114,450
Acquisition, integration, project and CEO
transition costs (2)                               3,597          15,691          26,230
Restructuring charges (3)                              -           4,358           1,881
Loss on extinguishment and modification of
debt (4)                                          19,027               -               -
Other (income) expense (5)                       (44,328 )           226               -
Adjusted EBITDA from continuing
operations, non-GAAP basis (6)               $   158,077     $   148,081     $   142,561


                                       30

--------------------------------------------------------------------------------


      (1) EBITDA from continuing operations is a non-GAAP financial measure.  We
          believe it is useful to investors to provide disclosures of our
          operating results on the same basis as that used by management.  You
          should not consider EBITDA from continuing operations in isolation or as
          a substitute for income from continuing operations determined in
          accordance with U.S. GAAP.


      (2) Acquisition, integration, project and CEO transition costs consist of
          pre-tax charges of $3,597, 15,691, and $26,230 for fiscal 2021, 2020,
          and 2019, respectively, incurred in connection with the acquisition and
          integration of Nutrisystem and other strategic projects and with the
          termination of our former CEO in February 2020 and the hiring of our new
          CEO in June 2020.


      (3) Restructuring charges in 2020 consist of pre-tax charges of $4,358
          primarily related to optimizing for growth and executing on our new
          strategy and eliminating certain compensation costs in response to the
          COVID-19 pandemic. Restructuring charges for 2019 consist of pre-tax
          charges of $1,881 related to integrating the Nutrisystem business and
          streamlining our corporate and operations support.


      (4) Loss on extinguishment and modification of debt consists of pre-tax
          charges of $19,027 in 2021 related to our entering into the new Credit
          Agreement on June 30, 2021, as further described in Note 10 of the notes
          to consolidated financial statements included in this report.


      (5) Other (income) expense consists of pre-tax income of ($44,328) and
          expense of $226 in 2021 and 2020, respectively, related to (i) realized
          and unrealized gains on our Sharecare Equity Security (applicable to
          2021 only), as further described in Note 12 of the notes to consolidated
          financial statements included in this report, and (ii) certain interest
          rate swap agreements that no longer qualify for hedge accounting
          treatment ("de-designated swaps") and require changes in fair value to
          be recognized each period in current earnings, as further described in
          Note 14 of the notes to consolidated financial statements included in
          this report.


      (6) Adjusted EBITDA from continuing operations is a non-GAAP financial
          measure. We exclude acquisition, integration, project and CEO transition
          costs, restructuring charges, loss on extinguishment and modification of
          debt, and other (income) expense from this measure because of its
          comparability to our historical operating results. We believe it is
          useful to investors to provide disclosures of our operating results on
          the same basis as that used by management.  You should not consider
          Adjusted EBITDA from continuing operations in isolation or as a
          substitute for income from continuing operations determined in
          accordance with U.S. GAAP. Additionally, because Adjusted EBITDA from
          continuing operations may be defined differently by other companies in
          the Company's industry, the non-GAAP financial measure presented here
          may not be comparable to similarly titled measures of other companies.



    •  Free cash flow is a non-GAAP measure and is defined by the Company as net
       cash flows provided by operating activities less (i) acquisition of
       property and equipment and (ii) settlement on derivatives not designated as
       hedges, plus proceeds from sale of equity securities.  We believe free cash
       flow is useful to management and investors to measure (i) our performance,
       (ii) the strength of the Company and its ability to generate cash, and
       (iii) the amount of cash that is available to repay debt or make other
       investments. A reconciliation of free cash flow to cash flows from
       operating activities (the most comparable U.S. GAAP measure) is set forth
       below. The amounts shown below represent consolidated figures that include
       the effects of owning Nutrisystem.



                                                       Year Ended December 31,
(In thousands)                                  2021            2020            2019
Net cash flows provided by operating
activities                                   $    87,123     $   169,447     $    82,305
Acquisition of property and equipment            (14,750 )       (15,525 )       (24,713 )
Settlement on derivatives not designated
as hedges                                         (6,697 )        (1,499 )             -
Proceeds from sale of equity securities            2,728               -               -
Free cash flow                               $    68,404     $   152,423     $    57,592


Outlook

Although there is significant uncertainty relating to the potential impacts of the ongoing COVID-19 pandemic on our business going forward, including the impact on member participation in our SilverSneakers programs, our ability to continue to attract paying subscribers for our Prime Fitness program, and the ultimate medium- and long-


                                       31

--------------------------------------------------------------------------------

term impact of the pandemic on the global economy, we expect our results from continuing operations for the short term to continue to be adversely impacted by COVID-19.

Executive Overview of Results

The key financial results for 2021 are:

   •  Revenues from continuing operations of $481.3 million compared to $437.7
      million for 2020; and


   •  Pre-tax income from continuing operations of $133.7 million compared to
      $74.4 million for 2020. Pre-tax income from continuing operations for 2021
      includes:


            o  $39.2 million of unrealized gains and $2.5 million of realized
               gains related to our equity ownership in Sharecare, compared to $0
               for the same period in 2020;


  o $34.8 million of interest expense compared to $43.5 million for 2020;


  o $6.5 million of marketing expenses, compared to $12.2 million for 2020;


            o  $3.6 million of acquisition, integration, project, and CEO
               transition costs compared to $15.7 million for 2020;


            o  $2.6 million of unrealized gains related to de-designated swaps,
               compared to unrealized losses of $0.2 million for 2020; and


            o  $0 million of restructuring and related charges compared to $4.4
               million for 2020;


   •  Loss from discontinued operations, net of income tax benefit, of $2.5
      million compared to $280.5 million for 2020.

Results of Operations

The following table sets forth the components of the consolidated statements of operations for the years ended December 31, 2021, 2020, and 2019 expressed as a percentage of revenues from continuing operations.


                                                         Year Ended December 31,
                                                   2021            2020            2019
Revenues                                             100.0 %         100.0 %         100.0 %
Cost of revenue (exclusive of depreciation
included below)                                       57.8 %          57.2 %          70.4 %
Marketing                                              1.4 %           2.8 %           2.8 %
Selling, general and administrative expenses           8.7 %           9.8 %           8.4 %
Depreciation expense                                   2.3 %           2.3 %           1.1 %
Restructuring and related charges                        -             1.0 %           0.3 %
Operating income (1)                                  29.8 %          27.0 %          17.0 %

Interest expense                                       7.2 %           9.9 %           6.6 %
Loss on extinguishment and modification of
debt                                                   4.0 %             -               -
Other (income) expense, net                           (9.2 )%          0.1 %             -
Income before income taxes (1)                        27.8 %          17.0 %          10.3 %
Income tax expense                                     5.5 %           4.0 %           3.2 %

Income from continuing operations (1)                 22.3 %          13.0 %           7.1 %
Loss from discontinued operations, net of
income tax                                            (0.5 )%        (64.1 )%        (52.4 )%
Net income (loss) (1)                                 21.8 %         (51.1 )%        (45.3 )%


(1) Figures may not add due to rounding.

Following is a discussion and analysis of our results of operations and financial condition, which should be read in conjunction with our consolidated financial statements and related notes included under Part II, Item 8 of this


                                       32

--------------------------------------------------------------------------------

report. Discussions of 2019 results and year-to-year comparisons between 2020 and 2019 are not included in this Form 10-K, and can be found in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of the our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

Revenues

Revenues from continuing operations were $481.3 million for 2021 compared to $437.7 million for 2020, an increase of $43.5 million, primarily as a result of a net increase in SilverSneakers revenue of $49.2 million driven by an increase in revenue-generating visits as the effects of the COVID-19 pandemic lessened compared to the prior year period. Beginning in March 2020, substantially all of our fitness partner locations temporarily closed, with some locations reopening in May and June and throughout the remainder of 2020. For 2020, the average monthly total participation levels of our SilverSneakers members were significantly below historical levels. As a result, revenues from PMPM fees represented 54% of SilverSneakers revenue for 2020, compared to 47% for the same period in 2021. This increase was partially offset by a net decrease of $6.8 million due to other revenue earned during the second quarter of 2020 (that did not recur in 2021) from a program with a large employer seeking to improve its employees' well-being during the COVID-19 pandemic.

Cost of Revenue

Cost of revenue from continuing operations (excluding depreciation) as a percentage of revenues increased from 2020 (57.2%) to 2021 (57.8%), primarily due to (i) an increase in participation levels, which led to higher visit costs as a percentage of revenues, particularly revenues from PMPM fees and (ii) an increase in the level of short-term incentive compensation based on the Company's financial performance against pre-established targets. This increase was slightly offset by decreases due to (i) a decrease in acquisition, integration, and project costs, and (ii) the fixed nature of certain costs that do not increase proportionately with increases in revenue. These costs represented a lower percentage of revenue during 2021 due to the increase in revenue compared to 2020.




Marketing Expenses

Marketing expenses from continuing operations as a percentage of revenues decreased from 2020 (2.8%) to 2021 (1.4%), primarily due to decreased spending in 2021 on SilverSneakers television advertising, due in part to the COVID-19 pandemic as well as a shift in our media mix towards more targeted digital marketing.

Selling, General and Administrative Expenses

Selling, general and administrative expenses from continuing operations as a percentage of revenues decreased from 2020 (9.8%) to 2021 (8.7%) primarily due to decreases in (i) acquisition, integration, and project costs and (ii) CEO transition-related expenses associated with the termination of our former CEO in February 2020 and the hiring of a new CEO in June 2020. These decreases were partially offset by increases in (i) costs to advance our strategy, such as our new omnichannel marketing platform, and (ii) an increase in the level of short-term incentive compensation based on the Company's financial performance against pre-established targets.

Depreciation Expense

Depreciation expense from continuing operations did not change materially from 2020 to 2021.

Restructuring and Related Charges

2019 Restructuring Plan

During the first quarter of 2019, we began a reorganization primarily related to integrating the Nutrisystem business and streamlining our corporate and operations support (the "2019 Restructuring Plan"). The 2019 Restructuring Plan concluded during the first quarter of 2020.

2020 COVID Restructuring Plan



                                       33

--------------------------------------------------------------------------------

During the second quarter of 2020, we began a reorganization plan primarily related to eliminating certain compensation costs in response to the COVID-19 pandemic in order to preserve our liquidity and manage our cash flows ("2020 COVID Restructuring Plan"). The 2020 COVID Restructuring Plan was completed during the third quarter of 2020.

2020 Restructuring Plan

During the third quarter of 2020, we began a reorganization plan primarily related to optimizing our business for growth and executing on our new strategy ("2020 Restructuring Plan"). The 2020 Restructuring Plan was completed during the fourth quarter of 2020.


We incurred restructuring charges under each of the 2019 Restructuring Plan, the
2020 COVID Restructuring Plan, and the 2020 Restructuring Plan as set forth
below. These expenses consist entirely of severance and other employee-related
costs.

                                        Year
                                 Ended December 31,
(In millions)                           2020              Cumulative To Date

2019 Restructuring Plan         $                0.5     $                2.4
2020 COVID Restructuring Plan                    0.8                      0.8
2020 Restructuring Plan                          3.1                      3.1
                                $                4.4     $                6.3



Interest Expense

Interest expense from continuing operations decreased by $8.7 million for 2021 compared to 2020, primarily driven by a decrease in cash interest due to (i) a lower average level of outstanding borrowings in 2021 compared to 2020 and (ii) a reduction in the LIBOR margin for Term B Loans under the Credit Agreement compared to the Prior Credit Agreement.

Loss on Extinguishment and Modification of Debt

Upon execution of the Credit Agreement on June 30, 2021, we recorded a loss on extinguishment of debt of $18.2 million. In addition, we incurred third-party costs of $0.8 million, which were recorded as loss on modification of debt. See Note 10 of the notes to consolidated financial statements included in this report for further information.

Other (Income) Expense, Net

Other (income) expense, net was ($44.3) million for 2021 compared to $0.2 million for 2020 due to (i) realized and unrealized gains on our Sharecare Equity Security totaling $41.7 million in 2021, as further described in Note 12 of the notes to consolidated financial statements included in this report, and (ii) changes in fair value of certain interest rate swap agreements that, effective in the fourth quarter of 2020, no longer qualify for hedge accounting treatment ("de-designated swaps"). The combined unrealized and realized gains on our Sharecare Equity Security of $41.7 million increased earnings per diluted share by $0.83 during 2021.

Income Tax Expense

See Note 8 of the notes to consolidated financial statements in this report for a discussion of income tax expense for 2021 compared to fiscal 2020. For the fourth quarter of 2021, we had income tax expense of $9.6 million on a pre-tax loss of $15.4 million, primarily due to the income tax implications of an unrealized loss of $41.4 million related to the change in fair value of the Sharecare Equity Security (as defined in Note 12 in the notes to consolidated financial statements included in this report). The income tax benefit that would have otherwise resulted from such unrealized loss was fully offset by income tax expense due to an increase in the valuation allowance on deferred tax assets related to capital loss carryforwards.


                                       34

--------------------------------------------------------------------------------

Liquidity and Capital Resources

Overview

As of December 31, 2021, outstanding debt under the Credit Agreement was $380.5 million, which represented $394.0 million of principal on the Term Loan B less deferred loan costs and original issue discount, and we had $60.1 million of cash and cash equivalents. In addition, we had working capital of $108.5 million, including the Sharecare Equity Security of $49.7 million, which is subject to restrictions on resale as further described in Note 12 of the notes to consolidated financial statements included in this report.

Sources of Liquidity

Our sources of liquidity primarily include cash on hand, cash flows from operations, and available credit under the Credit Agreement. As of December 31, 2021, availability under the Revolving Credit Facility totaled $99.5 million as calculated under the most restrictive covenant. We believe we have sufficient liquidity to fund our operations and meet our short-term and long-term obligations.

Cash Flows Provided by Operating Activities

Operating activities during 2021 provided cash of $87.1 million compared to $169.4 million during 2020. The decrease is primarily due to (i) reduced cash flows from operating activities from Nutrisystem, which we sold in December 2020, and (ii) reduced cash collections on accounts receivable, primarily due to the fact that collections during the first several months of 2020 were related to billable visits that occurred prior to the negative impacts on our business from the COVID-19 pandemic and were therefore significantly higher than the same period in 2021. These reductions were partially offset by decreased payments related to interest and income taxes.

Cash Flows Provided by/Used in Investing Activities

Investing activities during 2021 used cash of $16.0 million, compared to cash provided of $541.0 million in 2020. This change is primarily due to proceeds from the sale of Nutrisystem in December 2020.

Cash Flows Used in Financing Activities

Financing activities during 2021 used cash of $111.4 million, compared to $612.6 million for 2020. This change is primarily due to a lower amount of net payments under the Prior Credit Agreement and the Credit Agreement during 2021 compared to 2020.

Material Cash Requirements

Our material cash requirements from known contractual and other obligations primarily relate to our debt and lease obligations. We generally do not have binding and enforceable purchase orders beyond the short term. In September 2021, our board of directors authorized the repurchase of up to $100 million of our common stock, with no expiration date. We are not obligated to repurchase any specific number of shares, and the timing and actual number of shares repurchased will depend on a variety of factors, including our stock price, general economic, business and market conditions, and alternative investment opportunities. The repurchase program may be modified or terminated by the Company's board of directors at any time.

We are required to repay the outstanding principal of $394.0 million under our Term Loan B in quarterly installments of $1.0 million, payable on the last day of each quarter until maturity on June 30, 2028, at which time the entire outstanding principal balance is due and payable in full. As a result of prepayments made in 2021, our next quarterly installment of $1.0 million is due in March 2023. We maintain eight amortizing interest rate swap agreements maturing in May 2024, of which three qualify for hedge accounting treatment and five are not considered effective hedges ("de-designated swaps"). Based on our outstanding borrowings under the Credit Agreement and the applicable interest rates as of December 31, 2021, we estimate that our total interest commitments are $125.6 million, with $24.9 million expected within the next twelve months.

In addition, based on the applicable interest rates as of December 31, 2021, we estimate that our total cash settlement obligations for the de-designated swaps are $10.6 million, with $5.7 million expected during 2022. Actual future payments may differ


                                       35

--------------------------------------------------------------------------------

from estimates. Refer to Notes 10 and 14 of the notes to the consolidated financial statements for further details on debt and interest rate swaps. As of December 31, 2021, we were in compliance with all of the financial covenant requirements of the Credit Agreement.

Additionally, we have operating and financing leases for office space, equipment, and a network server. Our two operating leases have remaining lease terms of 14 months and 33 months, and our two financing leases have remaining lease terms of less than one year. We maintain two sublease agreements with respect to one of our office locations, each of which continues through the initial term of our master agreement. At December 31, 2021, total future operating and finance lease payments are expected to be $11.6 million and $0.4 million, respectively. During 2022, operating and finance lease payments are expected to be $8.0 million and $0.4 million, respectively. The majority of future operating lease payments, including those due within the next twelve months, are expected to be offset by cash receipts from sublease contracts. Refer to Note 9 of the notes to the consolidated financial statements for further details. Finally, during 2022 we are required to pay $6.0 million to a vendor as a deposit to be applied against our actual fees incurred during 2022 and beyond. Any unused portion of the deposit will be refunded at the end of the contract term.

While the COVID-19 pandemic has created significant uncertainty as to general economic and market conditions for 2022 and beyond, as of the date of issuance of this report, we believe our cash on hand, expected cash flows from operations, and anticipated available credit under the Credit Agreement will be sufficient to fund our operations, principal and interest payments, and capital expenditures for the next 12 months. We cannot assure you that we will be able to secure additional financing if needed and, if such funds are available, whether the terms or conditions will be favorable to us. With the uncertainty surrounding COVID-19, our ability to engage in financing transactions may be constrained by (i) volatile or tight economic, capital, credit and/or financial market conditions, (ii) moderated investor and/or lender interest or capacity, (iii) restrictions under our Credit Agreement, and/or (iv) our liquidity, leverage and net worth, and we can provide no assurance as to successfully completing, the costs of, or the operational limitations arising from, any one or series of such transactions.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements as of December 31, 2021.

Recent Relevant Accounting Standards

See Note 3 of the notes to consolidated financial statements included in this report for discussion of recent relevant accounting standards.

© Edgar Online, source Glimpses

All news about TIVITY HEALTH, INC.
07/08TIVITY HEALTH, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
07/08Tivity Health, Inc. Terminates Adam Holland as Chief Financial Officer
CI
06/29TIVITY HEALTH, INC.(NASDAQGS : TVTY) dropped from S&P Health Care Services Select Industry..
CI
06/29TIVITY HEALTH, INC.(NASDAQGS : TVTY) dropped from S&P 600
CI
06/29TIVITY HEALTH, INC.(NASDAQGS : TVTY) dropped from S&P Composite 1500
CI
06/29TIVITY HEALTH, INC.(NASDAQGS : TVTY) dropped from S&P 600 Health Care
CI
06/29TIVITY HEALTH, INC.(NASDAQGS : TVTY) dropped from S&P Global BMI Index
CI
06/29TIVITY HEALTH, INC.(NASDAQGS : TVTY) dropped from S&P 1000
CI
06/29TIVITY HEALTH, INC.(NASDAQGS : TVTY) dropped from S&P 600 Health Care Services (Sub Ind)
CI
06/29TIVITY HEALTH, INC.(NASDAQGS : TVTY) dropped from S&P TMI Index
CI
More news
Analyst Recommendations on TIVITY HEALTH, INC.
More recommendations